124 related articles for article (PubMed ID: 30726629)
1. Idebenone (Raxone°) and Leber hereditary optic neuropathy.
Prescrire Int; 2017 Feb; 26(179):41. PubMed ID: 30726629
[No Abstract] [Full Text] [Related]
2. Idebenone for Leber's hereditary optic neuropathy.
Gueven N
Drugs Today (Barc); 2016 Mar; 52(3):173-81. PubMed ID: 27186591
[TBL] [Abstract][Full Text] [Related]
3. [Raxone in the Leber optical neuropathy: Parisian experience].
Orssaud C; Bidot S; Lamirel C; Brémond Gignac D; Touitou V; Vignal C
J Fr Ophtalmol; 2019 Mar; 42(3):269-275. PubMed ID: 30712826
[TBL] [Abstract][Full Text] [Related]
4. Idebenone treatment in Leber's hereditary optic neuropathy.
Carelli V; La Morgia C; Valentino ML; Rizzo G; Carbonelli M; De Negri AM; Sadun F; Carta A; Guerriero S; Simonelli F; Sadun AA; Aggarwal D; Liguori R; Avoni P; Baruzzi A; Zeviani M; Montagna P; Barboni P
Brain; 2011 Sep; 134(Pt 9):e188. PubMed ID: 21810891
[No Abstract] [Full Text] [Related]
5. Idebenone in Friedreich ataxia and Leber's hereditary optic neuropathy: close mechanisms, similar therapy?
Schiff M; Rustin P
Brain; 2016 Jul; 139(Pt 7):e39. PubMed ID: 27095078
[No Abstract] [Full Text] [Related]
6. Rapid visual recovery after coenzyme q10 treatment of leber hereditary optic neuropathy.
Huang CC; Kuo HC; Chu CC; Kao LY
J Neuroophthalmol; 2002 Mar; 22(1):66. PubMed ID: 11937918
[No Abstract] [Full Text] [Related]
7. Novel use of idebenone in Leber's hereditary optic neuropathy in Hong Kong.
Cheng SW; Ko CH; Yau SK; Mak C; Yuen YF; Lee CY
Hong Kong Med J; 2014 Oct; 20(5):451-4. PubMed ID: 25307075
[TBL] [Abstract][Full Text] [Related]
8. Idebenone: A Review in Leber's Hereditary Optic Neuropathy.
Lyseng-Williamson KA
Drugs; 2016 May; 76(7):805-13. PubMed ID: 27071925
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic Effects of Idebenone on Leber Hereditary Optic Neuropathy.
Zhao X; Zhang Y; Lu L; Yang H
Curr Eye Res; 2020 Oct; 45(10):1315-1323. PubMed ID: 32111141
[No Abstract] [Full Text] [Related]
10. Treatment of Leber hereditary optic neuropathy.
Newman NJ
Brain; 2011 Sep; 134(Pt 9):2447-50. PubMed ID: 21859767
[No Abstract] [Full Text] [Related]
11. Is Leber hereditary optic neuropathy treatable? Encouraging results with idebenone in both prospective and retrospective trials and an illustrative case.
Sabet-Peyman EJ; Khaderi KR; Sadun AA
J Neuroophthalmol; 2012 Mar; 32(1):54-7. PubMed ID: 22269948
[TBL] [Abstract][Full Text] [Related]
12. A randomized placebo-controlled trial of idebenone in Leber's hereditary optic neuropathy.
Klopstock T; Yu-Wai-Man P; Dimitriadis K; Rouleau J; Heck S; Bailie M; Atawan A; Chattopadhyay S; Schubert M; Garip A; Kernt M; Petraki D; Rummey C; Leinonen M; Metz G; Griffiths PG; Meier T; Chinnery PF
Brain; 2011 Sep; 134(Pt 9):2677-86. PubMed ID: 21788663
[TBL] [Abstract][Full Text] [Related]
13. Effects of idebenone on color vision in patients with leber hereditary optic neuropathy.
Rudolph G; Dimitriadis K; Büchner B; Heck S; Al-Tamami J; Seidensticker F; Rummey C; Leinonen M; Meier T; Klopstock T
J Neuroophthalmol; 2013 Mar; 33(1):30-6. PubMed ID: 23263355
[TBL] [Abstract][Full Text] [Related]
14. International Consensus Statement on the Clinical and Therapeutic Management of Leber Hereditary Optic Neuropathy.
Carelli V; Carbonelli M; de Coo IF; Kawasaki A; Klopstock T; Lagrèze WA; La Morgia C; Newman NJ; Orssaud C; Pott JWR; Sadun AA; van Everdingen J; Vignal-Clermont C; Votruba M; Yu-Wai-Man P; Barboni P
J Neuroophthalmol; 2017 Dec; 37(4):371-381. PubMed ID: 28991104
[TBL] [Abstract][Full Text] [Related]
15. Real-World Clinical Experience With Idebenone in the Treatment of Leber Hereditary Optic Neuropathy.
Catarino CB; von Livonius B; Priglinger C; Banik R; Matloob S; Tamhankar MA; Castillo L; Friedburg C; Halfpenny CA; Lincoln JA; Traber GL; Acaroglu G; Black GCM; Doncel C; Fraser CL; Jakubaszko J; Landau K; Langenegger SJ; Muñoz-Negrete FJ; Newman NJ; Poulton J; Scoppettuolo E; Subramanian P; Toosy AT; Vidal M; Vincent AL; Votruba M; Zarowski M; Zermansky A; Lob F; Rudolph G; Mikazans O; Silva M; Llòria X; Metz G; Klopstock T
J Neuroophthalmol; 2020 Dec; 40(4):558-565. PubMed ID: 32991388
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic benefit of idebenone in patients with Leber hereditary optic neuropathy: The LEROS nonrandomized controlled trial.
Yu-Wai-Man P; Carelli V; Newman NJ; Silva MJ; Linden A; Van Stavern G; Szaflik JP; Banik R; Lubiński W; Pemp B; Liao YJ; Subramanian PS; Misiuk-Hojło M; Newman S; Castillo L; Kocięcki J; Levin MH; Muñoz-Negrete FJ; Yagan A; Cherninkova S; Katz D; Meunier A; Votruba M; Korwin M; Dziedziak J; Jurkutė N; Harvey JP; La Morgia C; Priglinger C; Llòria X; Tomasso L; Klopstock T;
Cell Rep Med; 2024 Mar; 5(3):101437. PubMed ID: 38428428
[TBL] [Abstract][Full Text] [Related]
17. Persistence of the treatment effect of idebenone in Leber's hereditary optic neuropathy.
Klopstock T; Metz G; Yu-Wai-Man P; Büchner B; Gallenmüller C; Bailie M; Nwali N; Griffiths PG; von Livonius B; Reznicek L; Rouleau J; Coppard N; Meier T; Chinnery PF
Brain; 2013 Feb; 136(Pt 2):e230. PubMed ID: 23388409
[No Abstract] [Full Text] [Related]
18. Assessing the Treatment Effect of Idebenone in Leber Hereditary Optic Neuropathy Requires Appropriate Study Designs.
Finsterer J
J Neuroophthalmol; 2023 Sep; 43(3):e95-e96. PubMed ID: 34314394
[No Abstract] [Full Text] [Related]
19. Real-World Clinical Experience With Idebenone in the Treatment of Leber Hereditary Optic Neuropathy-Response to Dr. Finsterer's Letter.
Catarino CB; von Livonius B; Priglinger C; Landau K; Newman NJ; Votruba M; Rudolph G; Klopstock T
J Neuroophthalmol; 2023 Sep; 43(3):e96. PubMed ID: 34387631
[No Abstract] [Full Text] [Related]
20. Genetic variants affecting NQO1 protein levels impact the efficacy of idebenone treatment in Leber hereditary optic neuropathy.
Aleo SJ; Del Dotto V; Romagnoli M; Fiorini C; Capirossi G; Peron C; Maresca A; Caporali L; Capristo M; Tropeano CV; Zanna C; Ross-Cisneros FN; Sadun AA; Pignataro MG; Giordano C; Fasano C; Cavaliere A; Porcelli AM; Tioli G; Musiani F; Catania A; Lamperti C; Marzoli SB; De Negri A; Cascavilla ML; Battista M; Barboni P; Carbonelli M; Amore G; La Morgia C; Smirnov D; Vasilescu C; Farzeen A; Blickhaeuser B; Prokisch H; Priglinger C; Livonius B; Catarino CB; Klopstock T; Tiranti V; Carelli V; Ghelli AM
Cell Rep Med; 2024 Feb; 5(2):101383. PubMed ID: 38272025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
